GS1 Barcode requirements & User Manuals for medical supplies procured by MoHFW - NEW



Drugs & Cosmetics (4th amendment to rules 2009) - draft rules

Directory of Pharmaceutical Manufacturing Units in India

NPPA Compendium

Parliamentary Standing Committee On Health & Family Welfare On D&C (Amendment) Bill 2007

Draft Establishment Plan for the National Biotechnology Regulatory Authority


The Bill Proposing Constitution of Central Drug Authority of India

List of 294 FDCs Licensed by SLAs But Not Permitted by DCG (1)

IDMA's Pre-Budget Memorandum for 2008-09

USFDA - Nanotechnology Task Force Report July 25, 2007

Satwant Reddy Committee Report on Data Exclusivity dated May 31, 2007

Mashelkar panel report on Patent Law Issues

Report of the Joint Committee on Draft National Pharmaceutical Policy Submitted on Nov 30, 2006

Text of Order of Patent Controller Office rejecting Gleevac patent

Draft Pharma Policy, 2006 Part - A Dated December 28, 2005

Good Manufacturing Practices and requirements of premises, plant and equipment for In-Vitro diagnostic reagents / kits

The Patents (Amendment) Ordinance, 2004 (Ord. No. 7 of 2004)

Information on Japan regulatory affairs

List of 219 drugs included in Schedule-H in April 2004

Mashelkar committee report on regulatory structure & spurious drugs

National essential drugs list of Afghanistan

Requirements of the Drug Registration in the United Arab Emirates

Registration certificates issued for the following bulk drugs along with their manufacturing sites and Indian authorized agents till 15th February, 2003

Registration certificates issued for the following finished formulations along with their manufacturing sites and Indian authorized agents till 15th February, 2003

Sailent Features from Union Budget 2003-'04

Pre-Budget recommendations for Biotechnology

Karnataka High Court Order of Nov 12, 2002 upholding NPPA provision of revising prices in 15 days of notification

Registration certificates issued for the following bulk drugs alongwith their manufacturing sites and Indian authorized agents till 15th December, 2002

Drugs, finished formulations alongwith their manufacturing sites and Indian authorized agents registered for imports till 15th December, 2002

Global Pharmaceutical Report December 2002 By Ernst & Young

A Study on Availability and Prices of Medicines in India

OPPI's Code of Ethics for Advertisement of OTC drugs in India

Executive summary of the Report of the UK Commission on Intellectual Property Rights

Draft Guidelines on Stability Testing of Drug Substances and Products

The complete text of the Patents (Second Amendment) Bill, 2002

The complete text of National Health Policy-2002

DCGI clarifications on Import and Registration of drugs

Full text of the National AIDS prevention & control policy

Complete list of bulk drugs & formulations to be procured by 21 Latin American companies during their buyer-seller meet from March 7, 2002 in Hyderabad

ICH harmonised tripartite guideline for Stability Testing of new drug substances and products

Pharmaceutical Policy - 2002: Complete text

Guidelines before grant of approval for operation of whole human blood and/or its components storage centres run by first referral unit, community health centre, primary health centre or any hospital

FIP Position Paper on the impact of Genomics on the discovery and development of Genetic based medicines

Full text of Good Clinical Practices Guidelines for clinical studies in India prepared by Central Drugs Standard Control Organisation

LMCP study on Impaired Bioavailability of Rifampicin from Fixed Dose Combination (FDC) Formulations with Isoniazid

Full text of report of the joint committee on the patents (second amendment) bill, 1999

List of fixed dose of combinations of drugs banned by the Govt. of India

IMA Enquiry Commission Report on M4N and G4N derivatives of NDGA trial in Regional Cancer Centre (RCC)

An abstract of the study on poor bioavailability of rifampicin in FDCs for anti-TB therapy by Dr. Saranjit Singh, NIPER

Draft national policy on Indian Systems of Medicine 2001

Ethical policies on the Human Genome, Genetic Research and Services

Biotechnology - A vision;  A ten year perspective prepared by Department of Biotechnology

Andhra Pradesh Biotechnology Policy 2001

The complete text of the Millennium Biotech Policy announced by the Karnataka Government

GMP Guidelines for primary packaging materials used in pharmaceutical industry

Draft rules for Import and Registration of Drug & Pharmaceuticals

Report of the Sub Group of Under Task Force

List of single ingredient drugs and fixed dose combinations prohibited for sale in India since January 1984

Essential Ayurvedic Drugs For Dispensaries & Hopsitals

Guidelines for Generating Preclinical and Clinical Data for r-DNA Based Vaccines, Dignostics and other Biologicals

Good laboratory practice guidelines for drug testing laboratories in India

Summary and Recommendations of Drug Price Control Review Committee (DPCRC)

New drugs & devices approved by US FDA in 1999

The Biological Diversity Bill, 2000 drafted in April, 2000

General information for applicants for patents in India

List of the drugs reported to be not of standard quality by the Drugs Control Laboratory, Maharashtra

Notification for Ayurvedic, Siddha & Unani medicines

Check list for application for W.H.O. G.M.P. Certificate in Andhra Pradesh

Recommendations of Group II Task Force on Pharmaceuticals & Knowledge based Industries

Application formats, checklists and documents issued by the Andhra Pradesh Drugs Control Administration for the benefit of Drug Manufacturing Units in Andhra Pradesh 

The complete Pharmaceutical Research and Development Committee Report 

Proposal for registering the overseas manufacturers for their pharmaceutical products to be imported, used and marketed in India